BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 32498494)

  • 1. Long-Term Outcomes of Genetic Parkinson's Disease.
    Aasly JO
    J Mov Disord; 2020 May; 13(2):81-96. PubMed ID: 32498494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil.
    Abreu GM; Valença DC; Campos M; da Silva CP; Pereira JS; Araujo Leite MA; Rosso AL; Nicaretta DH; Vasconcellos LF; da Silva DJ; Della Coletta MV; Dos Santos JM; Gonçalves AP; Santos-Rebouças CB; Pimentel MM
    Neurosci Lett; 2016 Dec; 635():67-70. PubMed ID: 27777137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance.
    Hernandez DG; Reed X; Singleton AB
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl 1):59-74. PubMed ID: 27090875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.
    Benitez BA; Davis AA; Jin SC; Ibanez L; Ortega-Cubero S; Pastor P; Choi J; Cooper B; Perlmutter JS; Cruchaga C
    Mol Neurodegener; 2016 Apr; 11():29. PubMed ID: 27094865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort.
    Vollstedt EJ; Schaake S; Lohmann K; Padmanabhan S; Brice A; Lesage S; Tesson C; Vidailhet M; Wurster I; Hentati F; Mirelman A; Giladi N; Marder K; Waters C; Fahn S; Kasten M; Brüggemann N; Borsche M; Foroud T; Tolosa E; Garrido A; Annesi G; Gagliardi M; Bozi M; Stefanis L; Ferreira JJ; Correia Guedes L; Avenali M; Petrucci S; Clark L; Fedotova EY; Abramycheva NY; Alvarez V; Menéndez-González M; Jesús Maestre S; Gómez-Garre P; Mir P; Belin AC; Ran C; Lin CH; Kuo MC; Crosiers D; Wszolek ZK; Ross OA; Jankovic J; Nishioka K; Funayama M; Clarimon J; Williams-Gray CH; Camacho M; Cornejo-Olivas M; Torres-Ramirez L; Wu YR; Lee-Chen GJ; Morgadinho A; Pulkes T; Termsarasab P; Berg D; Kuhlenbäumer G; Kühn AA; Borngräber F; de Michele G; De Rosa A; Zimprich A; Puschmann A; Mellick GD; Dorszewska J; Carr J; Ferese R; Gambardella S; Chase B; Markopoulou K; Satake W; Toda T; Rossi M; Merello M; Lynch T; Olszewska DA; Lim SY; Ahmad-Annuar A; Tan AH; Al-Mubarak B; Hanagasi H; Koziorowski D; Ertan S; Genç G; de Carvalho Aguiar P; Barkhuizen M; Pimentel MMG; Saunders-Pullman R; van de Warrenburg B; Bressman S; Toft M; Appel-Cresswell S; Lang AE; Skorvanek M; Boon AJW; Krüger R; Sammler EM; Tumas V; Zhang BR; Garraux G; Chung SJ; Kim YJ; Winkelmann J; Sue CM; Tan EK; Damásio J; Klivényi P; Kostic VS; Arkadir D; Martikainen M; Borges V; Hertz JM; Brighina L; Spitz M; Suchowersky O; Riess O; Das P; Mollenhauer B; Gatto EM; Petersen MS; Hattori N; Wu RM; Illarioshkin SN; Valente EM; Aasly JO; Aasly A; Alcalay RN; Thaler A; Farrer MJ; Brockmann K; Corvol JC; Klein C;
    Mov Disord; 2023 Feb; 38(2):286-303. PubMed ID: 36692014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the genetic variability in Parkinson's disease from Southern Spain.
    Bandrés-Ciga S; Mencacci NE; Durán R; Barrero FJ; Escamilla-Sevilla F; Morgan S; Hehir J; Vives F; Hardy J; Pittman AM
    Neurobiol Aging; 2016 Jan; 37():210.e1-210.e5. PubMed ID: 26518746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genetic landscape of Parkinson's disease.
    Lunati A; Lesage S; Brice A
    Rev Neurol (Paris); 2018 Nov; 174(9):628-643. PubMed ID: 30245141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Genetic Testing in the Clinical Practice and Research of Early-Onset Parkinsonian Disorders in a Hungarian Cohort: Increasing Challenge in Genetic Counselling, Improving Chances in Stratification for Clinical Trials.
    Illés A; Csabán D; Grosz Z; Balicza P; Gézsi A; Molnár V; Bencsik R; Gál A; Klivényi P; Molnar MJ
    Front Genet; 2019; 10():1061. PubMed ID: 31737044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of Parkinson's disease--state of the art, 2013.
    Bonifati V
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S23-8. PubMed ID: 24262182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetic spectrum of a cohort of patients clinically diagnosed as Parkinson's disease in mainland China.
    Sun YM; Zhou XY; Liang XN; Lin JR; Xu YD; Chen C; Wei SD; Chen QS; Liu FT; Zhao J; Tang YL; Shen B; Gan LH; Lu B; Ding ZT; An Y; Wu JJ; Wang J
    NPJ Parkinsons Dis; 2023 May; 9(1):76. PubMed ID: 37198191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetic background of Parkinson's disease: current progress and future prospects.
    Kalinderi K; Bostantjopoulou S; Fidani L
    Acta Neurol Scand; 2016 Nov; 134(5):314-326. PubMed ID: 26869347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson's disease patients.
    Boros FA; Török R; Vágvölgyi-Sümegi E; Pesei ZG; Klivényi P; Vécsei L
    Neurosci Lett; 2019 Jul; 706():140-145. PubMed ID: 31085292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autosomal dominant Parkinson's disease.
    Sundal C; Fujioka S; Uitti RJ; Wszolek ZK
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S7-10. PubMed ID: 22166459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of mendelian genes in "sporadic" Parkinson's disease.
    Lesage S; Brice A
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S66-70. PubMed ID: 22166458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling Parkinson's Disease: Not Only Rodents?
    Shadrina M; Slominsky P
    Front Aging Neurosci; 2021; 13():695718. PubMed ID: 34421573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic landscape of Parkinson's disease and related diseases in Luxembourg.
    Landoulsi Z; Pachchek S; Bobbili DR; Pavelka L; May P; Krüger R;
    Front Aging Neurosci; 2023; 15():1282174. PubMed ID: 38173558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics of Parkinson's disease in the Polish population.
    Milanowski ŁM; Ross OA; Friedman A; Hoffman-Zacharska D; Gorka-Skoczylas P; Jurek M; Koziorowski D; Wszolek ZK
    Neurol Neurochir Pol; 2021; 55(3):241-252. PubMed ID: 33539026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leveraging genetic diversity to understand monogenic Parkinson's disease's landscape in AfrAbia.
    Mohamed W
    Am J Neurodegener Dis; 2023; 12(4):108-122. PubMed ID: 37736165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease.
    Yonova-Doing E; Atadzhanov M; Quadri M; Kelly P; Shawa N; Musonda ST; Simons EJ; Breedveld GJ; Oostra BA; Bonifati V
    Parkinsonism Relat Disord; 2012 Jun; 18(5):567-71. PubMed ID: 22445250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling Non-motor Symptoms in Monogenic Parkinson's Disease.
    Liu X; Le W
    Front Aging Neurosci; 2020; 12():591183. PubMed ID: 33192488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.